Streetbeat News

Regulatory

BLK

FNF

GDX

Issuers of Bitcoin ETFs are skeptical about the SEC's willingness to approve an Ethereum-based ETF, despite earlier approvals for Bitcoin ETFs. Companies like BlackRock, Fidelity, and VanEck, having faced delays and a lack of feedback on their ether ETF applications, express doubts, especially given the SEC's scrutiny of crypto assets under federal securities laws. CoinShares and Digital Finance Group CEOs also shared their skepticism, with the latter noting Ethereum's strong performance amid rumors of a U.S. ETF approval.

Portfolio Pulse from Benzinga Neuro

April 09, 2024 | 1:14 pm

BE

Bloom Energy Inc (NYSE:BE) shares are up in premarket trading after being awarded up to $75 million in tax credits by the Department of Energy, Treasury, and IRS under the Qualifying Advanced Energy Project 48C initiative. This funding, part of a $4 billion initiative announced by the White House, supports Bloom's expansion of domestic manufacturing and production capacity at its Fremont, California plant. The plant's output is significant for Bloom's Energy Server platform and Bloom Electrolyzer, contributing to the energy industry's decarbonization efforts.

Portfolio Pulse from Shivani Kumaresan

April 09, 2024 | 1:11 pm

HLTH

Cue Health announced a strategic review process to evaluate options, including a potential sale, as disclosed in an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 1:08 pm

NTES

NetEase shares are trading higher after reports that The National Press and Publication Administration approved 14 new imported games, potentially benefiting NetEase's gaming portfolio.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 1:07 pm

NTES

NetEase shares increased in premarket trading after reports emerged that the company received new game approvals from the National Press and Publication Administration. This development is significant as it could lead to increased revenues and market share in the gaming sector for NetEase.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 1:06 pm

CVKD

Cadrenal Therapeutics has been granted FDA Orphan Drug Designation for Tecarfarin, aimed at preventing thromboembolism and thrombosis in patients with various heart assist devices. This designation could lead to seven years of market exclusivity and more partnering opportunities post-approval.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 1:05 pm

EPD

Enterprise Products Partners L.P. (EPD) has been granted a deepwater port license for its Sea Port Oil Terminal (SPOT) project. This license allows EPD to progress with the development of the SPOT project, aimed at enhancing its oil export capabilities.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:52 pm

LSTA

Lisata Therapeutics has been granted Orphan Drug Designation by the U.S. FDA for its drug LSTA1, aimed at treating osteosarcoma. This designation is significant as it provides various benefits including tax credits, eligibility for market exclusivity, and assistance in the drug development process.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:41 pm

CHRO

Chromocell, under CEO Frank Knuettel II, announced the successful closure of its IPO on February 21, 2024, raising $6.6 million. The company converted all pre-IPO debt and Series A Preferred Stock to common stock and transferred liabilities in exchange for Series C Preferred Stock. Chromocell is focusing on developing non-opioid pain treatments, with its lead compound CC8464 completing Phase I trials and planning for Phase II. Another program, CT2000, targets acute and chronic eye pain. The company aims for fiscal responsibility, leveraging tax credits and exploring non-dilutive capital options.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:40 pm

SSL

Sasol's shares are trading higher after the Minister of Forestry, Fisheries and the Environment upheld Sasol South Africa's appeal, allowing a load-based limit for regulating sulphur dioxide emissions from the Secunda Operations' boilers.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:39 pm